Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia

BACKGROUND: Carbapenem is frequently used when gram negative bacilli (GNB) bacteremia is detected especially in neutropenic patients. Consequently, appropriate treatment could be delayed in GNB bacteremia cases involving organisms which are not susceptible to carbapenem (carba-NS), resulting in a po...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:BMC Infect Dis
Κύριοι συγγραφείς: Shin, Dong Hoon, Shin, Dong-Yeop, Kang, Chang Kyung, Park, Suhyeon, Park, Jieun, Jun, Kang Il, Kim, Taek Soo, Koh, Youngil, Hong, Jun Shik, Choe, Pyoeng Gyun, Park, Wan Beom, Kim, Nam-Joong, Yoon, Sung-soo, Kim, Inho, Oh, Myoung-don
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2020
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7282079/
https://ncbi.nlm.nih.gov/pubmed/32517658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-05131-2
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια